In-vitro activity of 29 antimicrobial agents against penicillin-resistant and -intermediate isolates of Streptococcus pneumoniae

Journal of Antimicrobial Chemotherapy

Volumn 43, Issue 1, 1999, Pages 31-36

  Manzor, O ^b   Pawlak, J ^a   Saravolatz, L ^c  

^a HENRY FORD HOSPITAL   (United States)

^b ST JOHN HOSPITAL AND MEDICAL CENTER   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPENICILLIN; AMPICILLIN; ANTIINFECTIVE AGENT; CARBAPENEM DERIVATIVE; CEFIXIME; CEFMETAZOLE; CEFOTAXIME; CEFOTETAN; CEFPROZIL; CEFTAZIDIME; CEFTIZOXIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CLAVULANIC ACID; CLINAFLOXACIN; DALFOPRISTIN; IMIPENEM; LINEZOLID; MACROLIDE; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINUPRISTIN; RAMOPLANIN; RIFAMPICIN; SULBACTAM; TEICOPLANIN; TROVAFLOXACIN; UNINDEXED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PENICILLIN RESISTANCE; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; CARBAPENEMS; CEFOTAXIME; CEFTRIAXONE; CEPHALOSPORINS; DRUG RESISTANCE, MULTIPLE; GLYCOPEPTIDES; MACROLIDES; MICROBIAL SENSITIVITY TESTS; PENICILLIN RESISTANCE; QUINOLONES; STREPTOCOCCUS PNEUMONIAE;

EID: 0032960358     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/43.1.31     Document Type: Article

References (23)

1. Jacobs, R. F., Kaplan, S. L., Schutze, G. E., Dajani, A. S., Leggiadro, R. J., Rim, C. S. et al. (1996). Relationship of MICs to efficacy of cefotaxime in treatment of Streptococcus pneumoniae infections. Antimicrobial Agents and Chemotherapy 40, 895-8.
2. Hansman, D. & Bullen, M. M. (1967). A resistant pneumococcus. Lancet ii, 264-5.
3. Appelbaum, P. C. (1992). Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clinical Infectious Diseases 15, 77-83.
4. Thornsberry, C., Ogilvie, P., Kahn, J. & Mauriz, Y. (1997). Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moxarella catarrhalis in the United States during the 1996-97 respiratory season. In Program and Abstracts of the Thirty-Fifth Annual Meeting of the Infectious Diseases Society of America, Abstract 52, p. 12. ISDA, San Francisco, CA, USA.
5. National Committee for Clinical Laboratory Standards. (1997). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically - Fourth Edition: Approved Standard M7-A4. NCCLS, Villanova, PA.
6. Jacobs, M. (1992). Treatment and diagnosis of infections caused by drug-resistant Streptococcus pneumoniae. Clinical Infectious Diseases 15, 119-27.
7. Donnelly, J. P. (1992) Describing and comparing in-vitro anti-microbial activity by the box-plot technique. Journal of Antimicrobial Chemotherapy 30, 713-9.
8. Shoukri, M. M. & Edge, V. L. (1996). Statistical Methods for Health Sciences. CRC Press, Boca Raton, FL.
9. Sanford, J. P., Gilbert, D. N. & Sande, M. A. (1996). Guide to Antimicrobial Therapy, 26th edn. Dallas, TX. Antimicrobial Therapy Incorporated, Vienna, VA, USA.
10. Mandell, G. L., Bennett, J. E. & Dolin, R. (1995). Mandell, Douglas and Bennett's Principles and Practices of Infectious Diseases, 4th edn. Churchill Livingstone, New York.
11. Vincent, J., Teng, R., Dogolo, L. C., Schumacer, D., Willavize, S. A. & Friedman, H. L. (1996). Trovafloxacin and ofloxacin profiles in ambulatory subjects matched for age and gender. In Program and Abstracts of the Thirty-Sixth Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, LA, 1996. Abstract A6, p. 2. American Society for Microbiology, Washington, DC.
12. Friedland, I. R. & McCracken, G. H. (1994). Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. New England Journal of Medicine 331, 377-82.
13. McDougal, L. K., Facklam, R., Reeves, M., Hunter, S., Swenson, J. M., Hill, B. C. et al. (1992). Analysis of multiple antimicrobial-resistant isolates of Streptococcus pneumoniae from the United States. Antimicrobial Agents and Chemotherapy 36, 2176-84.
14. Kleiman, M. D., Weinberg, G. A., Reynolds, J. K. & Allen, S. D. (1993). Meningitis with β-lactam resistant Streptococcus pneumoniae: the need for early repeat lumbar puncture. Pediatric Infectious Disease Journal 12, 782-4.
15. Musher, D. M. (1992). Infections caused by Streptococcus pneumonias: clinical spectrum, pathogenesis, immunity, and treatment. Clinical Infectious Diseases 14, 801-7.
16. Koornhof, H. J., Wasas, A. & Klugman, K. (1992). Antimicrobial resistance in Streptococcus pneumoniae: a South African perspective. Clinical Infectious Diseases 15, 84-94.
17. Marshall, K. J., Musher, D. M., Watson, D. & Mason, E. O. (1993). Testing of Streptococcus pneumoniae for resistance to penicillin. Journal of Clinical Microbiology 31, 1246-50.
18. Sigler, A. J. & Trexler-Hessen, M. (1993). Antibiotic resistance in clinically important gram-positive cocci. Infections in Medicine 10, 20, 37-40, 43.
19. Klugman, K. P., Friedland, I. R. & Bradley, J. S. (1995). Bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with acute bacterial meningitis. Antimicrobial Agents and Chemotherapy 39, 1988-92.
20. Paris, M. M., Ramilo, O. & MaCraken, G. H. (1995). Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy 39, 2171-5.
21. D'Amato, R. F. D., Swenson, J. M., McKinley, G. A., Hochstein, L., Wallman, A. A., Cleri, D. J. et al. (1987). Quantitative antimicrobial susceptibility test for Streptococcus pneumoniae using inoculum supplemented with whole defibrinated sheep blood. Journal of Clinical Microbiology 25, 1753-6.
22. Chesney, P. J. (1992). The escalating problem of antimicrobial resistance in Streptococcus pneumoniae. American Journal of Diseases of Children 146, 912-6.
23. Bron, N. J., Dorr, M. B., Mant, T. G., Webb, C. L. & Vassos, A. B. (1996). The tolerance and pharmacokinetics of clinofloxacin (Cl-960) in healthy subjects. Journal of Antimicrobial Chemotherapy 38, 1023-9.